About Sam Goldberger
Form D filings for Hubble Therapeutics in 2024 list Sam Goldberger as director.
Sam Goldberger first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Sam Goldberger in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sam Goldberger works with at each company, as listed on that company's latest Form D.
Hubble Therapeutics, LLC · Form D, Oct 21, 2024
JS
Jeff Sabados
Chief Executive Officer and director
GK
Greg Keenan
Director